Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 13/20 | 0.49 |
| ▸ | RIOK2 | Q9BVS4 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29652162 | 1.00 | KCNH2 (0.49) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL3424094 | 1.00 | KCNH2 (0.49) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL29652161 | 1.00 | KCNH2 (0.49) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL3173642 | 0.99 | KCNH2 (0.48) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL3173652 | 0.99 | KCNH2 (0.48) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL6212285 | 0.99 | KCNH2 (0.48) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL4207580 | 0.99 | KCNH2 (0.48) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL3173648 | 0.91 | KCNH2 (0.41) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL4207578 | 0.91 | KCNH2 (0.41) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL29743296 | 0.91 | KCNH2 (0.41) | KCNH2RIOK2KDM4EALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4244385-B1 | LOOP MEDIATED ISOTHERMAL NUCLEIC ACID AMPLIFICATION (LAMP) USING LNA-MODIFIED PRIMERS AND A METAL-BASED COLORIMETRIC METHOD FOR DETECTING AN AMPLIFICATION PRODUCT | MULTIPLEXDX S R O (SK) | 2025-01-01 | — | — | EP | claimed |
| CN-118435055-A | Compositions and methods for detecting enzymatic pyrophosphate products using pyridine azo aniline dyes | 新英格兰生物实验室公司 | 2024-08-02 | — | — | CN | claimed |
| US-20240026435-A1 | LOOP MEDIATED ISOTHERMAL NUCLEIC ACID AMPLIFICATION (LAMP) USING LNA-MODIFIED PRIMERS AND A METAL-BASED COLORIMETRIC METHOD FOR DETECTING AN AMPLIFICATION PRODUCT | MultiplexDX, s.r.o. (SK) | 2024-01-25 | — | — | US | claimed |
| CN-117417986-A | Method for rapidly detecting target nucleic acid sequence based on 5-Br-PAPS | 浙江大学杭州国际科创中心 | 2024-01-19 | — | — | CN | claimed |
| CN-116802315-A | Loop-mediated isothermal nucleic acid amplification (LAMP) using LNA modified primers and metal-based colorimetric detection of amplified products | 马尔提普莱克斯公司 | 2023-09-22 | — | — | CN | claimed |
| EP-4244385-A1 | LOOP MEDIATED ISOTHERMAL NUCLEIC ACID AMPLIFICATION (LAMP) USING LNA-MODIFIED PRIMERS AND A METAL-BASED COLORIMETRIC METHOD FOR DETECTING AN AMPLIFICATION PRODUCT | MultiplexDX, s.r.o. (SK) | 2023-09-20 | — | — | EP | claimed |
| WO-2023076772-A1 | COMPOSITIONS AND METHODS FOR DETECTING PYROPHOSPHATE PRODUCTS OF ENZYME REACTIONS USING PYRIDYLAZOANILINE DYES | NEW ENGLAND BIOLABS, INC. (US) | 2023-05-04 | — | — | WO | claimed |
| EP-4174491-A1 | COMPOSITIONS AND METHODS FOR DETECTING PYROPHOSPHATE PRODUCTS OF ENZYME REACTIONS USING PYRIDYLAZOANILINE DYES | NEW ENGLAND BIOLABS, INC. (US) | 2023-05-03 | — | — | EP | claimed |
| US-11512342-B1 | Compositions and methods for detecting pyrophosphate products of enzyme reactions using pyridylazoaniline dyes | NEW ENGLAND BIOLABS, INC. (US) | 2022-11-29 | — | — | US | claimed |
| WO-2022101259-A1 | LOOP MEDIATED ISOTHERMAL NUCLEIC ACID AMPLIFICATION (LAMP) USING LNA-MODIFIED PRIMERS AND A METAL-BASED COLORIMETRIC METHOD FOR DETECTING AN AMPLIFICATION PRODUCT | MultiplexDX, s.r.o. (SK) | 2022-05-19 | — | — | WO | claimed |
| US-20110046204-A1 | Human Zip1, Zinc and Citrate for Prostate Cancer Screening | UNIVERSITY OF MARYLAND, BALITMORE | 2011-02-24 | — | — | US | claimed |
| US-20110020943-A1 | DRY TESTING TOOL, METHOD FOR MEASURING METAL, AND METHOD FOR PRODUCING DRY TESTING TOOL | ARKRAY, INC. (JP) | 2011-01-27 | — | — | US | claimed |
| EP-2261656-A1 | DRY TEST INSTRUMENT, METHOD OF MEASURING METAL AND METHOD OF PRODUCING DRY TEST INSTRUMENT | ARKRAY, Inc. (JP) | 2010-12-15 | — | — | EP | claimed |
| US-20100061891-A1 | Flow analysis system capable of quantitatively or semi-quantitatively determining element in sample | CANON SEMICONDUCTOR EQUIPMENT INC. (JP) | 2010-03-11 | — | — | US | claimed |
| EP-1977248-A4 | HUMAN ZIP1, ZINC AND CITRATE FOR PROSTATE CANCER SCREENING | UNIV MARYLAND (US) | 2009-08-05 | — | — | EP | claimed |
| US-20090017545-A1 | Method of Determining Metal by Colorimetry and Determination Reagent | SHINO-TEST CORPORATION (JP) | 2009-01-15 | — | — | US | claimed |
| EP-1992943-A1 | METHOD OF DETERMINING METAL BY COLORIMETRY AND DETERMINATION REAGENT | SHINO-TEST CORPORATION (JP) | 2008-11-19 | — | — | EP | claimed |
| EP-1977248-A2 | HUMAN ZIP1, ZINC AND CITRATE FOR PROSTATE CANCER SCREENING | THE UNIVERSITY OF MARYLAND AT BALTIMORE (US) | 2008-10-08 | — | — | EP | claimed |
| US-20070292900-A1 | Zinc-based screening test and kit for early diagnosis of prostate cancer | ANDRO DIAGNOSTICS, INC. | 2007-12-20 | — | — | US | claimed |
| WO-2007087263-A2 | HUMAN ZIP1, ZINC AND CITRATE FOR PROSTATE CANCER SCREENING | THE UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2007-08-02 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090017545-A1 | Method of Determining Metal by Colorimetry and Determination Reagent | FECH, SLC30A5, SLC30A6 | KCNH2 2344/4885RIOK2 4600/4885KDM4E 2407/4885 |
| US-20110046204-A1 | Human Zip1, Zinc and Citrate for Prostate Cancer Screening | SLC39A11, SLC39A3, SLC30A5 | KCNH2 3722/4885RIOK2 4319/4885KDM4E 3987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.